CQP(SZ:000950) Zheng Quan Zhi Xing·2025-07-15 16:08Core Viewpoint - The company has announced a share repurchase plan approved by its board of directors, detailing the top ten shareholders and their respective holdings as of the day before the announcement [1][2]. Group 1: Share Repurchase Announcement - The board of directors of Chongqing Pharmaceutical Holdings Co., Ltd. approved a share repurchase plan on July 10, 2025 [1]. - The details of the share repurchase plan were disclosed on July 12, 2025, in a separate announcement [1]. Group 2: Top Ten Shareholders - The announcement includes the names, share quantities, and ownership percentages of the top ten shareholders as of July 11, 2025 [1]. - The top shareholder is Chongqing Yufu Capital Equity Investment Fund Management Co., Ltd. with a significant holding [1]. - The second shareholder is China Merchants Bank Co., Ltd. - Southern CSI 1000 ETF, indicating a diversified shareholder base [1]. Group 3: Top Ten Unrestricted Shareholders - The same entities listed as top shareholders are also noted as the top ten unrestricted shareholders, reflecting consistency in ownership [2]. - The holdings are reported as the total number of shares after combining ordinary accounts and margin trading accounts [2].